?>
Logo

PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 401k Plan overview

Plan NamePHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST
Plan identification number 001

PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
  • Plan sponsor(s) received services of leased employees, as defined in Code section 414(n), during the plan year.

401k Sponsoring company profile

PHARMACEUTICS INTERNATIONAL, INC. has sponsored the creation of one or more 401k plans.

Company Name:PHARMACEUTICS INTERNATIONAL, INC.
Employer identification number (EIN):521901342
NAIC Classification:325410

Form 5500 Filing Information

Submission information for form 5500 for 401k plan PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0012022-01-01
0012021-01-01
0012020-01-01
0012019-01-01
0012018-01-01
0012017-01-01JILL DETTINGER
0012016-01-01JILL DETTINGER JILL DETTINGER2017-10-12
0012015-01-01JILL DETTINGER JILL DETTINGER2016-10-12
0012014-01-01JILL DETTINGER
0012013-01-01JILL DETTINGER
0012012-01-01JILL DETTINGER
0012011-01-01JILL DETTINGER
0012010-01-01JILL DETTINGER
0012009-01-01JILL DETTINGER

Plan Statistics for PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST

401k plan membership statisitcs for PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST

Measure Date Value
2022: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2022 401k membership
Total participants, beginning-of-year2022-01-01398
Total number of active participants reported on line 7a of the Form 55002022-01-01242
Number of retired or separated participants receiving benefits2022-01-010
Number of other retired or separated participants entitled to future benefits2022-01-01189
Total of all active and inactive participants2022-01-01431
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2022-01-011
Total participants2022-01-01432
Number of participants with account balances2022-01-01414
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2022-01-010
2021: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2021 401k membership
Total participants, beginning-of-year2021-01-01414
Total number of active participants reported on line 7a of the Form 55002021-01-01220
Number of retired or separated participants receiving benefits2021-01-010
Number of other retired or separated participants entitled to future benefits2021-01-01176
Total of all active and inactive participants2021-01-01396
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2021-01-010
Total participants2021-01-01396
Number of participants with account balances2021-01-01387
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2021-01-010
2020: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2020 401k membership
Total participants, beginning-of-year2020-01-01407
Total number of active participants reported on line 7a of the Form 55002020-01-01289
Number of retired or separated participants receiving benefits2020-01-010
Number of other retired or separated participants entitled to future benefits2020-01-01126
Total of all active and inactive participants2020-01-01415
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2020-01-010
Total participants2020-01-01415
Number of participants with account balances2020-01-01400
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2020-01-010
2019: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2019 401k membership
Total participants, beginning-of-year2019-01-01447
Total number of active participants reported on line 7a of the Form 55002019-01-01248
Number of retired or separated participants receiving benefits2019-01-010
Number of other retired or separated participants entitled to future benefits2019-01-01182
Total of all active and inactive participants2019-01-01430
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2019-01-010
Total participants2019-01-01430
Number of participants with account balances2019-01-01419
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2019-01-010
2018: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2018 401k membership
Total participants, beginning-of-year2018-01-01474
Total number of active participants reported on line 7a of the Form 55002018-01-01260
Number of retired or separated participants receiving benefits2018-01-010
Number of other retired or separated participants entitled to future benefits2018-01-01181
Total of all active and inactive participants2018-01-01441
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2018-01-010
Total participants2018-01-01441
Number of participants with account balances2018-01-01435
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2018-01-012
2017: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2017 401k membership
Total participants, beginning-of-year2017-01-01548
Total number of active participants reported on line 7a of the Form 55002017-01-01318
Number of retired or separated participants receiving benefits2017-01-010
Number of other retired or separated participants entitled to future benefits2017-01-01150
Total of all active and inactive participants2017-01-01468
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2017-01-010
Total participants2017-01-01468
Number of participants with account balances2017-01-01405
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2017-01-010
2016: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2016 401k membership
Total participants, beginning-of-year2016-01-01621
Total number of active participants reported on line 7a of the Form 55002016-01-01462
Number of retired or separated participants receiving benefits2016-01-010
Number of other retired or separated participants entitled to future benefits2016-01-01120
Total of all active and inactive participants2016-01-01582
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2016-01-010
Total participants2016-01-01582
Number of participants with account balances2016-01-01480
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2016-01-010
2015: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2015 401k membership
Total participants, beginning-of-year2015-01-01600
Total number of active participants reported on line 7a of the Form 55002015-01-01497
Number of retired or separated participants receiving benefits2015-01-010
Number of other retired or separated participants entitled to future benefits2015-01-01114
Total of all active and inactive participants2015-01-01611
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2015-01-010
Total participants2015-01-01611
Number of participants with account balances2015-01-01502
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2015-01-016
2014: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2014 401k membership
Total participants, beginning-of-year2014-01-01561
Total number of active participants reported on line 7a of the Form 55002014-01-01524
Number of retired or separated participants receiving benefits2014-01-010
Number of other retired or separated participants entitled to future benefits2014-01-0181
Total of all active and inactive participants2014-01-01605
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2014-01-010
Total participants2014-01-01605
Number of participants with account balances2014-01-01493
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2014-01-014
2013: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2013 401k membership
Total participants, beginning-of-year2013-01-01465
Total number of active participants reported on line 7a of the Form 55002013-01-01485
Number of retired or separated participants receiving benefits2013-01-017
Total of all active and inactive participants2013-01-01492
Total participants2013-01-01492
Number of participants with account balances2013-01-01473
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2013-01-0118
2012: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2012 401k membership
Total participants, beginning-of-year2012-01-01507
Total number of active participants reported on line 7a of the Form 55002012-01-01437
Number of retired or separated participants receiving benefits2012-01-0166
Total of all active and inactive participants2012-01-01503
Total participants2012-01-01503
Number of participants with account balances2012-01-01465
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2012-01-0125
2011: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2011 401k membership
Total participants, beginning-of-year2011-01-01393
Total number of active participants reported on line 7a of the Form 55002011-01-01445
Number of retired or separated participants receiving benefits2011-01-010
Number of other retired or separated participants entitled to future benefits2011-01-0162
Total of all active and inactive participants2011-01-01507
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2011-01-010
Total participants2011-01-01507
Number of participants with account balances2011-01-01424
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2011-01-0135
2010: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2010 401k membership
Total participants, beginning-of-year2010-01-01325
Total number of active participants reported on line 7a of the Form 55002010-01-01324
Number of retired or separated participants receiving benefits2010-01-010
Number of other retired or separated participants entitled to future benefits2010-01-0136
Total of all active and inactive participants2010-01-01360
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2010-01-010
Total participants2010-01-01360
Number of participants with account balances2010-01-01354
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2010-01-0131
2009: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2009 401k membership
Total participants, beginning-of-year2009-01-01411
Total number of active participants reported on line 7a of the Form 55002009-01-01339
Number of retired or separated participants receiving benefits2009-01-010
Number of other retired or separated participants entitled to future benefits2009-01-0161
Total of all active and inactive participants2009-01-01400
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2009-01-010
Total participants2009-01-01400
Number of participants with account balances2009-01-01398
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2009-01-0139

Financial Data on PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST

Measure Date Value
2022 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2022 401k financial data
Total unrealized appreciation/depreciation of assets2022-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total income from all sources (including contributions)2022-12-31$-155,341
Total loss/gain on sale of assets2022-12-31$0
Total of all expenses incurred2022-12-31$3,099,172
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-12-31$3,031,464
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-12-31$2,485,820
Value of total assets at end of year2022-12-31$17,362,361
Value of total assets at beginning of year2022-12-31$20,616,874
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-12-31$67,708
Total interest from all sources2022-12-31$75,332
Total dividends received (eg from common stock, registered investment company shares)2022-12-31$130,652
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2022-12-31$130,652
Administrative expenses professional fees incurred2022-12-31$18,281
Was this plan covered by a fidelity bond2022-12-31Yes
Value of fidelity bond cover2022-12-31$500,000
If this is an individual account plan, was there a blackout period2022-12-31No
Were there any nonexempt tranactions with any party-in-interest2022-12-31No
Contributions received from participants2022-12-31$1,383,134
Participant contributions at end of year2022-12-31$253,827
Participant contributions at beginning of year2022-12-31$195,774
Income. Received or receivable in cash from other sources (including rollovers)2022-12-31$391,708
Other income not declared elsewhere2022-12-31$7,524
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Value of net income/loss2022-12-31$-3,254,513
Value of net assets at end of year (total assets less liabilities)2022-12-31$17,362,361
Value of net assets at beginning of year (total assets less liabilities)2022-12-31$20,616,874
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2022-12-31No
Were any leases to which the plan was party in default or uncollectible2022-12-31No
Investment advisory and management fees2022-12-31$10,969
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-12-31$9,338,109
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-12-31$11,651,418
Value of interest in pooled separate accounts at end of year2022-12-31$3,431,027
Value of interest in pooled separate accounts at beginning of year2022-12-31$4,009,143
Interest on participant loans2022-12-31$10,438
Interest earned on other investments2022-12-31$64,894
Value of interest in common/collective trusts at end of year2022-12-31$350,886
Value of interest in common/collective trusts at beginning of year2022-12-31$413,779
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2022-12-31$3,988,512
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2022-12-31$4,346,760
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-12-31$-1,926,823
Net investment gain/loss from pooled separate accounts2022-12-31$-860,422
Net investment gain or loss from common/collective trusts2022-12-31$-67,424
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-12-31No
Was there a failure to transmit to the plan any participant contributions2022-12-31No
Has the plan failed to provide any benefit when due under the plan2022-12-31No
Contributions received in cash from employer2022-12-31$710,978
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-12-31$3,031,464
Contract administrator fees2022-12-31$38,458
Did the plan have assets held for investment2022-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-12-31No
Opinion of an independent qualified public accountant for this plan2022-12-31Unqualified
Accountancy firm name2022-12-31ELLIN & TUCKER, CHARTERED
Accountancy firm EIN2022-12-31520959934
2021 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2021 401k financial data
Total unrealized appreciation/depreciation of assets2021-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total income from all sources (including contributions)2021-12-31$4,781,768
Total loss/gain on sale of assets2021-12-31$0
Total of all expenses incurred2021-12-31$4,844,284
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2021-12-31$4,770,735
Expenses. Certain deemed distributions of participant loans2021-12-31$629
Total contributions o plan (from employers,participants, others, non cash contrinutions)2021-12-31$3,000,373
Value of total assets at end of year2021-12-31$20,616,874
Value of total assets at beginning of year2021-12-31$20,679,390
Total of administrative expenses incurred including professional, contract, advisory and management fees2021-12-31$72,920
Total interest from all sources2021-12-31$81,758
Total dividends received (eg from common stock, registered investment company shares)2021-12-31$111,082
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2021-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2021-12-31$111,082
Administrative expenses professional fees incurred2021-12-31$19,861
Was this plan covered by a fidelity bond2021-12-31Yes
Value of fidelity bond cover2021-12-31$500,000
If this is an individual account plan, was there a blackout period2021-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2021-12-31$0
Were there any nonexempt tranactions with any party-in-interest2021-12-31No
Contributions received from participants2021-12-31$1,421,530
Participant contributions at end of year2021-12-31$195,774
Participant contributions at beginning of year2021-12-31$439,646
Participant contributions at beginning of year2021-12-31$51,223
Income. Received or receivable in cash from other sources (including rollovers)2021-12-31$866,595
Other income not declared elsewhere2021-12-31$1,223
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Value of net income/loss2021-12-31$-62,516
Value of net assets at end of year (total assets less liabilities)2021-12-31$20,616,874
Value of net assets at beginning of year (total assets less liabilities)2021-12-31$20,679,390
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2021-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2021-12-31No
Were any leases to which the plan was party in default or uncollectible2021-12-31No
Investment advisory and management fees2021-12-31$11,917
Value of interest in registered invesment companies (eg mutual funds) at end of year2021-12-31$11,651,418
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2021-12-31$11,635,402
Value of interest in pooled separate accounts at end of year2021-12-31$4,009,143
Value of interest in pooled separate accounts at beginning of year2021-12-31$4,029,038
Interest on participant loans2021-12-31$14,209
Interest earned on other investments2021-12-31$67,549
Value of interest in common/collective trusts at end of year2021-12-31$413,779
Value of interest in common/collective trusts at beginning of year2021-12-31$159,856
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2021-12-31$4,346,760
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2021-12-31$4,336,589
Net investment gain/loss from registered investment companies (e.g. mutual funds)2021-12-31$732,092
Net investment gain/loss from pooled separate accounts2021-12-31$823,216
Net investment gain or loss from common/collective trusts2021-12-31$32,024
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2021-12-31No
Was there a failure to transmit to the plan any participant contributions2021-12-31No
Has the plan failed to provide any benefit when due under the plan2021-12-31No
Contributions received in cash from employer2021-12-31$712,248
Employer contributions (assets) at beginning of year2021-12-31$27,636
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2021-12-31$4,770,735
Contract administrator fees2021-12-31$41,142
Did the plan have assets held for investment2021-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2021-12-31No
Opinion of an independent qualified public accountant for this plan2021-12-31Unqualified
Accountancy firm name2021-12-31ELLIN & TUCKER,
Accountancy firm EIN2021-12-31520959934
2020 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2020 401k financial data
Unrealized appreciation/depreciation of real estate assets2020-12-31$0
Unrealized appreciation/depreciation of other (non real estate) assets2020-12-31$0
Total unrealized appreciation/depreciation of assets2020-12-31$0
Total transfer of assets to this plan2020-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Expenses. Interest paid2020-12-31$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-1022020-12-31$0
Total income from all sources (including contributions)2020-12-31$3,183,782
Total loss/gain on sale of assets2020-12-31$0
Total of all expenses incurred2020-12-31$3,800,630
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2020-12-31$3,621,222
Expenses. Certain deemed distributions of participant loans2020-12-31$49,152
Value of total corrective distributions2020-12-31$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)2020-12-31$2,412,917
Value of total assets at end of year2020-12-31$20,679,390
Value of total assets at beginning of year2020-12-31$21,296,238
Total of administrative expenses incurred including professional, contract, advisory and management fees2020-12-31$130,256
Total income from rents2020-12-31$0
Total interest from all sources2020-12-31$42,241
Total dividends received (eg from common stock, registered investment company shares)2020-12-31$186,665
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2020-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2020-12-31$186,665
Administrative expenses professional fees incurred2020-12-31$0
Was this plan covered by a fidelity bond2020-12-31Yes
Value of fidelity bond cover2020-12-31$1,000,000
If this is an individual account plan, was there a blackout period2020-12-31Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2020-12-31$0
Were there any nonexempt tranactions with any party-in-interest2020-12-31No
Amount of non-exempt transactions with any party-in-interest2020-12-31$0
Contributions received from participants2020-12-31$1,581,231
Participant contributions at end of year2020-12-31$439,646
Participant contributions at beginning of year2020-12-31$575,485
Participant contributions at end of year2020-12-31$51,223
Participant contributions at beginning of year2020-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2020-12-31$20,768
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)2020-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at end of year2020-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2020-12-31$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2020-12-31$0
Other income not declared elsewhere2020-12-31$11,290
Administrative expenses (other) incurred2020-12-31$0
Liabilities. Value of operating payables at beginning of year2020-12-31$0
Total non interest bearing cash at end of year2020-12-31$0
Total non interest bearing cash at beginning of year2020-12-31$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Income. Non cash contributions2020-12-31$0
Value of net income/loss2020-12-31$-616,848
Value of net assets at end of year (total assets less liabilities)2020-12-31$20,679,390
Value of net assets at beginning of year (total assets less liabilities)2020-12-31$21,296,238
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2020-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2020-12-31No
Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year2020-12-31$0
Were any leases to which the plan was party in default or uncollectible2020-12-31No
Amount of leases to which the plan was a party which were in default/classified-as-uncollectible during the year2020-12-31$0
Investment advisory and management fees2020-12-31$0
Value of interest in registered invesment companies (eg mutual funds) at end of year2020-12-31$11,635,402
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2020-12-31$16,821,734
Value of interest in pooled separate accounts at end of year2020-12-31$4,029,038
Value of interest in pooled separate accounts at beginning of year2020-12-31$0
Interest on participant loans2020-12-31$25,990
Income. Interest from loans (other than to participants)2020-12-31$0
Interest earned on other investments2020-12-31$16,251
Income. Interest from US Government securities2020-12-31$0
Income. Interest from corporate debt instruments2020-12-31$0
Value of interest in common/collective trusts at end of year2020-12-31$159,856
Value of interest in common/collective trusts at beginning of year2020-12-31$3,899,019
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2020-12-31$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2020-12-31$4,336,589
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2020-12-31$0
Expenses. Payments to insurance carriers foe the provision of benefits2020-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2020-12-31$19,358
Net investment gain/loss from pooled separate accounts2020-12-31$296,441
Net investment gain or loss from common/collective trusts2020-12-31$214,870
Net gain/loss from 103.12 investment entities2020-12-31$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2020-12-31No
Was there a failure to transmit to the plan any participant contributions2020-12-31No
Has the plan failed to provide any benefit when due under the plan2020-12-31No
Contributions received in cash from employer2020-12-31$810,918
Employer contributions (assets) at end of year2020-12-31$27,636
Employer contributions (assets) at beginning of year2020-12-31$0
Income. Dividends from preferred stock2020-12-31$0
Income. Dividends from common stock2020-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2020-12-31$3,621,222
Contract administrator fees2020-12-31$130,256
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32020-12-31Yes
Liabilities. Value of benefit claims payable at beginning of year2020-12-31$0
Did the plan have assets held for investment2020-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2020-12-31No
Aggregate proceeds on sale of assets2020-12-31$0
Aggregate carrying amount (costs) on sale of assets2020-12-31$0
Liabilities. Value of acquisition indebtedness at beginning of year2020-12-31$0
Opinion of an independent qualified public accountant for this plan2020-12-31Disclaimer
Accountancy firm name2020-12-31ELLIN & TUCKER
Accountancy firm EIN2020-12-31520959934
2019 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2019 401k financial data
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total transfer of assets to this plan2019-12-31$0
Total transfer of assets from this plan2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total income from all sources (including contributions)2019-12-31$6,293,342
Total loss/gain on sale of assets2019-12-31$0
Total of all expenses incurred2019-12-31$5,493,696
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$5,346,274
Expenses. Certain deemed distributions of participant loans2019-12-31$45,835
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$2,475,297
Value of total assets at end of year2019-12-31$21,296,238
Value of total assets at beginning of year2019-12-31$20,496,592
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$101,587
Total interest from all sources2019-12-31$35,415
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$506,713
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$506,713
Was this plan covered by a fidelity bond2019-12-31Yes
Value of fidelity bond cover2019-12-31$500,000
If this is an individual account plan, was there a blackout period2019-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2019-12-31$0
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Contributions received from participants2019-12-31$1,583,062
Participant contributions at end of year2019-12-31$575,485
Participant contributions at beginning of year2019-12-31$615,642
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$98,306
Other income not declared elsewhere2019-12-31$297
Administrative expenses (other) incurred2019-12-31$101,587
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Value of net income/loss2019-12-31$799,646
Value of net assets at end of year (total assets less liabilities)2019-12-31$21,296,238
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$20,496,592
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$16,821,734
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$15,880,152
Interest on participant loans2019-12-31$35,415
Value of interest in common/collective trusts at end of year2019-12-31$3,899,019
Value of interest in common/collective trusts at beginning of year2019-12-31$4,000,798
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$3,162,737
Net investment gain or loss from common/collective trusts2019-12-31$112,883
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Contributions received in cash from employer2019-12-31$793,929
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$5,346,274
Did the plan have assets held for investment2019-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Accountancy firm name2019-12-31ELLIN & TUCKER
Accountancy firm EIN2019-12-31520959934
2018 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2018 401k financial data
Total unrealized appreciation/depreciation of assets2018-12-31$0
Total transfer of assets to this plan2018-12-31$0
Total transfer of assets from this plan2018-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total income from all sources (including contributions)2018-12-31$536,386
Total loss/gain on sale of assets2018-12-31$0
Total of all expenses incurred2018-12-31$2,248,651
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2018-12-31$2,080,578
Expenses. Certain deemed distributions of participant loans2018-12-31$61,306
Total contributions o plan (from employers,participants, others, non cash contrinutions)2018-12-31$2,248,848
Value of total assets at end of year2018-12-31$20,496,592
Value of total assets at beginning of year2018-12-31$22,208,857
Total of administrative expenses incurred including professional, contract, advisory and management fees2018-12-31$106,767
Total interest from all sources2018-12-31$32,276
Total dividends received (eg from common stock, registered investment company shares)2018-12-31$727,909
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2018-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2018-12-31$727,909
Was this plan covered by a fidelity bond2018-12-31Yes
Value of fidelity bond cover2018-12-31$500,000
If this is an individual account plan, was there a blackout period2018-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2018-12-31$0
Were there any nonexempt tranactions with any party-in-interest2018-12-31No
Contributions received from participants2018-12-31$1,452,643
Participant contributions at end of year2018-12-31$615,642
Participant contributions at beginning of year2018-12-31$644,554
Income. Received or receivable in cash from other sources (including rollovers)2018-12-31$28,671
Other income not declared elsewhere2018-12-31$-5,199
Administrative expenses (other) incurred2018-12-31$106,767
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Value of net income/loss2018-12-31$-1,712,265
Value of net assets at end of year (total assets less liabilities)2018-12-31$20,496,592
Value of net assets at beginning of year (total assets less liabilities)2018-12-31$22,208,857
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2018-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2018-12-31No
Were any leases to which the plan was party in default or uncollectible2018-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2018-12-31$15,880,152
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2018-12-31$17,326,698
Interest on participant loans2018-12-31$32,276
Value of interest in common/collective trusts at end of year2018-12-31$4,000,798
Value of interest in common/collective trusts at beginning of year2018-12-31$4,237,605
Net investment gain/loss from registered investment companies (e.g. mutual funds)2018-12-31$-2,551,024
Net investment gain or loss from common/collective trusts2018-12-31$83,576
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2018-12-31No
Was there a failure to transmit to the plan any participant contributions2018-12-31No
Has the plan failed to provide any benefit when due under the plan2018-12-31No
Contributions received in cash from employer2018-12-31$767,534
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2018-12-31$2,080,578
Did the plan have assets held for investment2018-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2018-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2018-12-31Yes
Opinion of an independent qualified public accountant for this plan2018-12-31Disclaimer
Accountancy firm name2018-12-31ELLIN & TUCKER
Accountancy firm EIN2018-12-31520959934
2017 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2017 401k financial data
Total unrealized appreciation/depreciation of assets2017-12-31$0
Total transfer of assets from this plan2017-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total income from all sources (including contributions)2017-12-31$5,616,348
Total loss/gain on sale of assets2017-12-31$0
Total of all expenses incurred2017-12-31$7,386,742
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2017-12-31$7,204,373
Expenses. Certain deemed distributions of participant loans2017-12-31$49,992
Total contributions o plan (from employers,participants, others, non cash contrinutions)2017-12-31$2,274,724
Value of total assets at end of year2017-12-31$22,208,857
Value of total assets at beginning of year2017-12-31$23,979,251
Total of administrative expenses incurred including professional, contract, advisory and management fees2017-12-31$132,377
Total interest from all sources2017-12-31$28,046
Total dividends received (eg from common stock, registered investment company shares)2017-12-31$419,924
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2017-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2017-12-31$419,924
Was this plan covered by a fidelity bond2017-12-31Yes
Value of fidelity bond cover2017-12-31$500,000
If this is an individual account plan, was there a blackout period2017-12-31Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2017-12-31$0
Were there any nonexempt tranactions with any party-in-interest2017-12-31No
Contributions received from participants2017-12-31$1,472,180
Participant contributions at end of year2017-12-31$644,554
Participant contributions at beginning of year2017-12-31$765,500
Income. Received or receivable in cash from other sources (including rollovers)2017-12-31$60,722
Other income not declared elsewhere2017-12-31$9,515
Administrative expenses (other) incurred2017-12-31$132,377
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Value of net income/loss2017-12-31$-1,770,394
Value of net assets at end of year (total assets less liabilities)2017-12-31$22,208,857
Value of net assets at beginning of year (total assets less liabilities)2017-12-31$23,979,251
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2017-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2017-12-31No
Were any leases to which the plan was party in default or uncollectible2017-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2017-12-31$17,326,698
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2017-12-31$17,872,267
Interest on participant loans2017-12-31$28,046
Value of interest in common/collective trusts at end of year2017-12-31$4,237,605
Value of interest in common/collective trusts at beginning of year2017-12-31$5,341,484
Net investment gain/loss from registered investment companies (e.g. mutual funds)2017-12-31$2,866,580
Net investment gain or loss from common/collective trusts2017-12-31$17,559
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2017-12-31No
Was there a failure to transmit to the plan any participant contributions2017-12-31No
Has the plan failed to provide any benefit when due under the plan2017-12-31No
Contributions received in cash from employer2017-12-31$741,822
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2017-12-31$7,204,373
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32017-12-31Yes
Did the plan have assets held for investment2017-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2017-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2017-12-31Yes
Opinion of an independent qualified public accountant for this plan2017-12-31Disclaimer
Accountancy firm name2017-12-31ELLIN & TUCKER
Accountancy firm EIN2017-12-31520959934
2016 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2016 401k financial data
Total unrealized appreciation/depreciation of assets2016-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total income from all sources (including contributions)2016-12-31$4,731,180
Total loss/gain on sale of assets2016-12-31$0
Total of all expenses incurred2016-12-31$3,763,492
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2016-12-31$3,569,649
Expenses. Certain deemed distributions of participant loans2016-12-31$77,697
Total contributions o plan (from employers,participants, others, non cash contrinutions)2016-12-31$2,610,717
Value of total assets at end of year2016-12-31$23,979,588
Value of total assets at beginning of year2016-12-31$23,011,900
Total of administrative expenses incurred including professional, contract, advisory and management fees2016-12-31$116,146
Total interest from all sources2016-12-31$33,864
Total dividends received (eg from common stock, registered investment company shares)2016-12-31$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2016-12-31No
Was this plan covered by a fidelity bond2016-12-31Yes
Value of fidelity bond cover2016-12-31$4,000,000
If this is an individual account plan, was there a blackout period2016-12-31No
Were there any nonexempt tranactions with any party-in-interest2016-12-31No
Contributions received from participants2016-12-31$1,694,364
Participant contributions at end of year2016-12-31$765,837
Participant contributions at beginning of year2016-12-31$812,744
Income. Received or receivable in cash from other sources (including rollovers)2016-12-31$55,838
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Value of net income/loss2016-12-31$967,688
Value of net assets at end of year (total assets less liabilities)2016-12-31$23,979,588
Value of net assets at beginning of year (total assets less liabilities)2016-12-31$23,011,900
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2016-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2016-12-31No
Were any leases to which the plan was party in default or uncollectible2016-12-31No
Investment advisory and management fees2016-12-31$66,340
Value of interest in registered invesment companies (eg mutual funds) at end of year2016-12-31$17,872,267
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2016-12-31$17,613,524
Interest on participant loans2016-12-31$33,864
Value of interest in common/collective trusts at end of year2016-12-31$5,341,484
Value of interest in common/collective trusts at beginning of year2016-12-31$4,585,632
Net investment gain/loss from registered investment companies (e.g. mutual funds)2016-12-31$2,025,657
Net investment gain or loss from common/collective trusts2016-12-31$60,942
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2016-12-31No
Was there a failure to transmit to the plan any participant contributions2016-12-31No
Has the plan failed to provide any benefit when due under the plan2016-12-31No
Contributions received in cash from employer2016-12-31$860,515
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2016-12-31$3,569,649
Contract administrator fees2016-12-31$49,806
Did the plan have assets held for investment2016-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2016-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2016-12-31Yes
Opinion of an independent qualified public accountant for this plan2016-12-31Disclaimer
Accountancy firm name2016-12-31POLAN & HOLLIS LLC
Accountancy firm EIN2016-12-31273174787
2015 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2015 401k financial data
Total unrealized appreciation/depreciation of assets2015-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total income from all sources (including contributions)2015-12-31$2,834,891
Total loss/gain on sale of assets2015-12-31$0
Total of all expenses incurred2015-12-31$1,544,798
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2015-12-31$1,409,453
Expenses. Certain deemed distributions of participant loans2015-12-31$17,653
Total contributions o plan (from employers,participants, others, non cash contrinutions)2015-12-31$2,955,421
Value of total assets at end of year2015-12-31$23,011,900
Value of total assets at beginning of year2015-12-31$21,721,807
Total of administrative expenses incurred including professional, contract, advisory and management fees2015-12-31$117,692
Total interest from all sources2015-12-31$30,855
Total dividends received (eg from common stock, registered investment company shares)2015-12-31$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2015-12-31No
Was this plan covered by a fidelity bond2015-12-31Yes
Value of fidelity bond cover2015-12-31$4,000,000
If this is an individual account plan, was there a blackout period2015-12-31No
Were there any nonexempt tranactions with any party-in-interest2015-12-31No
Contributions received from participants2015-12-31$1,833,383
Participant contributions at end of year2015-12-31$812,744
Participant contributions at beginning of year2015-12-31$702,061
Income. Received or receivable in cash from other sources (including rollovers)2015-12-31$154,601
Administrative expenses (other) incurred2015-12-31$4,995
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Value of net income/loss2015-12-31$1,290,093
Value of net assets at end of year (total assets less liabilities)2015-12-31$23,011,900
Value of net assets at beginning of year (total assets less liabilities)2015-12-31$21,721,807
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2015-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2015-12-31No
Were any leases to which the plan was party in default or uncollectible2015-12-31No
Investment advisory and management fees2015-12-31$69,554
Value of interest in registered invesment companies (eg mutual funds) at end of year2015-12-31$17,613,524
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2015-12-31$16,517,757
Interest on participant loans2015-12-31$30,855
Value of interest in common/collective trusts at end of year2015-12-31$4,585,632
Value of interest in common/collective trusts at beginning of year2015-12-31$4,501,989
Net investment gain/loss from registered investment companies (e.g. mutual funds)2015-12-31$-193,467
Net investment gain or loss from common/collective trusts2015-12-31$42,082
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2015-12-31No
Was there a failure to transmit to the plan any participant contributions2015-12-31No
Has the plan failed to provide any benefit when due under the plan2015-12-31No
Contributions received in cash from employer2015-12-31$967,437
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2015-12-31$1,409,453
Contract administrator fees2015-12-31$43,143
Did the plan have assets held for investment2015-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2015-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2015-12-31Yes
Opinion of an independent qualified public accountant for this plan2015-12-31Disclaimer
Accountancy firm name2015-12-31POLAN & HOLLIS LLC
Accountancy firm EIN2015-12-31273174787
2014 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2014 401k financial data
Total unrealized appreciation/depreciation of assets2014-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total income from all sources (including contributions)2014-12-31$3,277,702
Total loss/gain on sale of assets2014-12-31$0
Total of all expenses incurred2014-12-31$931,905
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2014-12-31$807,014
Expenses. Certain deemed distributions of participant loans2014-12-31$1,154
Total contributions o plan (from employers,participants, others, non cash contrinutions)2014-12-31$2,762,172
Value of total assets at end of year2014-12-31$21,721,807
Value of total assets at beginning of year2014-12-31$19,376,010
Total of administrative expenses incurred including professional, contract, advisory and management fees2014-12-31$123,737
Total interest from all sources2014-12-31$29,553
Total dividends received (eg from common stock, registered investment company shares)2014-12-31$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2014-12-31No
Was this plan covered by a fidelity bond2014-12-31Yes
Value of fidelity bond cover2014-12-31$4,000,000
If this is an individual account plan, was there a blackout period2014-12-31No
Were there any nonexempt tranactions with any party-in-interest2014-12-31No
Contributions received from participants2014-12-31$1,722,257
Participant contributions at end of year2014-12-31$702,061
Participant contributions at beginning of year2014-12-31$602,147
Participant contributions at beginning of year2014-12-31$69,456
Income. Received or receivable in cash from other sources (including rollovers)2014-12-31$101,151
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Value of net income/loss2014-12-31$2,345,797
Value of net assets at end of year (total assets less liabilities)2014-12-31$21,721,807
Value of net assets at beginning of year (total assets less liabilities)2014-12-31$19,376,010
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2014-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2014-12-31No
Were any leases to which the plan was party in default or uncollectible2014-12-31No
Investment advisory and management fees2014-12-31$79,145
Value of interest in registered invesment companies (eg mutual funds) at end of year2014-12-31$16,517,757
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2014-12-31$18,669,856
Interest on participant loans2014-12-31$29,553
Value of interest in common/collective trusts at end of year2014-12-31$4,501,989
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2014-12-31$478
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2014-12-31$478
Net investment gain/loss from registered investment companies (e.g. mutual funds)2014-12-31$450,376
Net investment gain or loss from common/collective trusts2014-12-31$35,601
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2014-12-31No
Was there a failure to transmit to the plan any participant contributions2014-12-31No
Has the plan failed to provide any benefit when due under the plan2014-12-31No
Contributions received in cash from employer2014-12-31$938,764
Employer contributions (assets) at beginning of year2014-12-31$34,073
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2014-12-31$807,014
Contract administrator fees2014-12-31$44,592
Did the plan have assets held for investment2014-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2014-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2014-12-31Yes
Opinion of an independent qualified public accountant for this plan2014-12-31Disclaimer
Accountancy firm name2014-12-31POLAN AND HOLLIS, LLC
Accountancy firm EIN2014-12-31273174787
2013 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2013 401k financial data
Total unrealized appreciation/depreciation of assets2013-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total income from all sources (including contributions)2013-12-31$5,808,420
Total loss/gain on sale of assets2013-12-31$0
Total of all expenses incurred2013-12-31$1,063,809
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2013-12-31$900,530
Expenses. Certain deemed distributions of participant loans2013-12-31$57,936
Total contributions o plan (from employers,participants, others, non cash contrinutions)2013-12-31$2,515,162
Value of total assets at end of year2013-12-31$19,376,010
Value of total assets at beginning of year2013-12-31$14,631,399
Total of administrative expenses incurred including professional, contract, advisory and management fees2013-12-31$105,343
Total interest from all sources2013-12-31$25,020
Total dividends received (eg from common stock, registered investment company shares)2013-12-31$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2013-12-31No
Was this plan covered by a fidelity bond2013-12-31Yes
Value of fidelity bond cover2013-12-31$900,000
If this is an individual account plan, was there a blackout period2013-12-31No
Were there any nonexempt tranactions with any party-in-interest2013-12-31No
Contributions received from participants2013-12-31$1,538,112
Participant contributions at end of year2013-12-31$602,147
Participant contributions at beginning of year2013-12-31$491,637
Participant contributions at end of year2013-12-31$69,456
Participant contributions at beginning of year2013-12-31$63,990
Income. Received or receivable in cash from other sources (including rollovers)2013-12-31$128,596
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Value of net income/loss2013-12-31$4,744,611
Value of net assets at end of year (total assets less liabilities)2013-12-31$19,376,010
Value of net assets at beginning of year (total assets less liabilities)2013-12-31$14,631,399
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2013-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2013-12-31No
Were any leases to which the plan was party in default or uncollectible2013-12-31No
Investment advisory and management fees2013-12-31$62,213
Value of interest in registered invesment companies (eg mutual funds) at end of year2013-12-31$18,669,856
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2013-12-31$14,038,395
Interest on participant loans2013-12-31$25,020
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2013-12-31$478
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2013-12-31$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2013-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2013-12-31$3,268,238
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2013-12-31No
Was there a failure to transmit to the plan any participant contributions2013-12-31No
Has the plan failed to provide any benefit when due under the plan2013-12-31No
Contributions received in cash from employer2013-12-31$848,454
Employer contributions (assets) at end of year2013-12-31$34,073
Employer contributions (assets) at beginning of year2013-12-31$37,377
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2013-12-31$900,530
Contract administrator fees2013-12-31$43,130
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32013-12-31No
Did the plan have assets held for investment2013-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2013-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2013-12-31Yes
Opinion of an independent qualified public accountant for this plan2013-12-31Disclaimer
Accountancy firm name2013-12-31POLAN AND HOLLIS, LLC
Accountancy firm EIN2013-12-31273174787
2012 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2012 401k financial data
Total unrealized appreciation/depreciation of assets2012-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total income from all sources (including contributions)2012-12-31$4,112,557
Total loss/gain on sale of assets2012-12-31$0
Total of all expenses incurred2012-12-31$1,349,983
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2012-12-31$1,258,086
Expenses. Certain deemed distributions of participant loans2012-12-31$6,808
Value of total corrective distributions2012-12-31$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)2012-12-31$2,510,621
Value of total assets at end of year2012-12-31$14,631,399
Value of total assets at beginning of year2012-12-31$11,868,825
Total of administrative expenses incurred including professional, contract, advisory and management fees2012-12-31$85,089
Total interest from all sources2012-12-31$17,800
Total dividends received (eg from common stock, registered investment company shares)2012-12-31$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2012-12-31No
Was this plan covered by a fidelity bond2012-12-31Yes
Value of fidelity bond cover2012-12-31$900,000
If this is an individual account plan, was there a blackout period2012-12-31No
Were there any nonexempt tranactions with any party-in-interest2012-12-31No
Contributions received from participants2012-12-31$1,441,555
Participant contributions at end of year2012-12-31$491,637
Participant contributions at beginning of year2012-12-31$328,314
Participant contributions at end of year2012-12-31$63,990
Participant contributions at beginning of year2012-12-31$51,778
Income. Received or receivable in cash from other sources (including rollovers)2012-12-31$332,789
Administrative expenses (other) incurred2012-12-31$6,800
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Value of net income/loss2012-12-31$2,762,574
Value of net assets at end of year (total assets less liabilities)2012-12-31$14,631,399
Value of net assets at beginning of year (total assets less liabilities)2012-12-31$11,868,825
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2012-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2012-12-31No
Were any leases to which the plan was party in default or uncollectible2012-12-31No
Investment advisory and management fees2012-12-31$50,239
Value of interest in registered invesment companies (eg mutual funds) at end of year2012-12-31$14,038,395
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2012-12-31$11,239,350
Interest on participant loans2012-12-31$17,800
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2012-12-31$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2012-12-31$219,197
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2012-12-31$219,197
Net investment gain/loss from registered investment companies (e.g. mutual funds)2012-12-31$1,584,136
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2012-12-31No
Was there a failure to transmit to the plan any participant contributions2012-12-31No
Has the plan failed to provide any benefit when due under the plan2012-12-31No
Contributions received in cash from employer2012-12-31$736,277
Employer contributions (assets) at end of year2012-12-31$37,377
Employer contributions (assets) at beginning of year2012-12-31$30,186
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2012-12-31$1,258,086
Contract administrator fees2012-12-31$28,050
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32012-12-31No
Did the plan have assets held for investment2012-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2012-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2012-12-31Yes
Opinion of an independent qualified public accountant for this plan2012-12-31Disclaimer
Accountancy firm name2012-12-31POLAN AND HOLLIS, LLC
Accountancy firm EIN2012-12-31273174787
2011 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2011 401k financial data
Total unrealized appreciation/depreciation of assets2011-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$12,584
Total income from all sources (including contributions)2011-12-31$1,494,118
Total loss/gain on sale of assets2011-12-31$0
Total of all expenses incurred2011-12-31$616,363
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2011-12-31$514,562
Expenses. Certain deemed distributions of participant loans2011-12-31$19,946
Value of total corrective distributions2011-12-31$12,584
Total contributions o plan (from employers,participants, others, non cash contrinutions)2011-12-31$2,120,512
Value of total assets at end of year2011-12-31$11,868,825
Value of total assets at beginning of year2011-12-31$11,003,654
Total of administrative expenses incurred including professional, contract, advisory and management fees2011-12-31$69,271
Total interest from all sources2011-12-31$11,466
Total dividends received (eg from common stock, registered investment company shares)2011-12-31$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2011-12-31No
Was this plan covered by a fidelity bond2011-12-31Yes
Value of fidelity bond cover2011-12-31$900,000
If this is an individual account plan, was there a blackout period2011-12-31No
Were there any nonexempt tranactions with any party-in-interest2011-12-31No
Contributions received from participants2011-12-31$1,231,631
Participant contributions at end of year2011-12-31$328,314
Participant contributions at beginning of year2011-12-31$216,063
Participant contributions at end of year2011-12-31$51,778
Participant contributions at beginning of year2011-12-31$39,453
Income. Received or receivable in cash from other sources (including rollovers)2011-12-31$173,841
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2011-12-31$12,584
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Value of net income/loss2011-12-31$877,755
Value of net assets at end of year (total assets less liabilities)2011-12-31$11,868,825
Value of net assets at beginning of year (total assets less liabilities)2011-12-31$10,991,070
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2011-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2011-12-31No
Were any leases to which the plan was party in default or uncollectible2011-12-31No
Investment advisory and management fees2011-12-31$44,367
Value of interest in registered invesment companies (eg mutual funds) at end of year2011-12-31$11,239,350
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2011-12-31$10,446,575
Interest on participant loans2011-12-31$11,466
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2011-12-31$219,197
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2011-12-31$276,849
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2011-12-31$276,849
Net investment gain/loss from registered investment companies (e.g. mutual funds)2011-12-31$-637,860
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2011-12-31No
Was there a failure to transmit to the plan any participant contributions2011-12-31No
Has the plan failed to provide any benefit when due under the plan2011-12-31No
Contributions received in cash from employer2011-12-31$715,040
Employer contributions (assets) at end of year2011-12-31$30,186
Employer contributions (assets) at beginning of year2011-12-31$24,714
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2011-12-31$514,562
Contract administrator fees2011-12-31$24,904
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32011-12-31No
Did the plan have assets held for investment2011-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2011-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2011-12-31Yes
Opinion of an independent qualified public accountant for this plan2011-12-31Disclaimer
Accountancy firm name2011-12-31POLAN AND HOLLIS, LLC
Accountancy firm EIN2011-12-31273174787
2010 : PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2010 401k financial data
Total unrealized appreciation/depreciation of assets2010-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$12,584
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$17,802
Total income from all sources (including contributions)2010-12-31$3,140,031
Total loss/gain on sale of assets2010-12-31$0
Total of all expenses incurred2010-12-31$883,569
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2010-12-31$788,717
Expenses. Certain deemed distributions of participant loans2010-12-31$13,445
Value of total corrective distributions2010-12-31$17,802
Total contributions o plan (from employers,participants, others, non cash contrinutions)2010-12-31$1,760,429
Value of total assets at end of year2010-12-31$11,003,654
Value of total assets at beginning of year2010-12-31$8,752,410
Total of administrative expenses incurred including professional, contract, advisory and management fees2010-12-31$63,605
Total interest from all sources2010-12-31$10,395
Total dividends received (eg from common stock, registered investment company shares)2010-12-31$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2010-12-31No
Was this plan covered by a fidelity bond2010-12-31Yes
Value of fidelity bond cover2010-12-31$900,000
If this is an individual account plan, was there a blackout period2010-12-31No
Were there any nonexempt tranactions with any party-in-interest2010-12-31No
Contributions received from participants2010-12-31$1,038,913
Participant contributions at end of year2010-12-31$216,063
Participant contributions at beginning of year2010-12-31$228,637
Participant contributions at end of year2010-12-31$39,453
Participant contributions at beginning of year2010-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2010-12-31$170,364
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2010-12-31$12,584
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2010-12-31$17,802
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Value of net income/loss2010-12-31$2,256,462
Value of net assets at end of year (total assets less liabilities)2010-12-31$10,991,070
Value of net assets at beginning of year (total assets less liabilities)2010-12-31$8,734,608
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2010-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2010-12-31No
Were any leases to which the plan was party in default or uncollectible2010-12-31No
Investment advisory and management fees2010-12-31$35,950
Value of interest in registered invesment companies (eg mutual funds) at end of year2010-12-31$10,446,575
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2010-12-31$8,404,562
Interest on participant loans2010-12-31$10,395
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2010-12-31$276,849
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2010-12-31$119,211
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2010-12-31$119,211
Net investment gain/loss from registered investment companies (e.g. mutual funds)2010-12-31$1,369,207
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2010-12-31No
Was there a failure to transmit to the plan any participant contributions2010-12-31No
Has the plan failed to provide any benefit when due under the plan2010-12-31No
Contributions received in cash from employer2010-12-31$551,152
Employer contributions (assets) at end of year2010-12-31$24,714
Employer contributions (assets) at beginning of year2010-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2010-12-31$788,717
Contract administrator fees2010-12-31$27,655
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32010-12-31No
Did the plan have assets held for investment2010-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2010-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2010-12-31Yes
Opinion of an independent qualified public accountant for this plan2010-12-31Disclaimer
Accountancy firm name2010-12-31POLAN AND HOLLIS, LLC
Accountancy firm EIN2010-12-31273174787

Form 5500 Responses for PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST

2022: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2022 form 5500 responses
2022-01-01Type of plan entitySingle employer plan
2022-01-01This submission is the final filingNo
2022-01-01This return/report is a short plan year return/report (less than 12 months)No
2022-01-01Plan is a collectively bargained planNo
2022-01-01Plan funding arrangement – InsuranceYes
2022-01-01Plan funding arrangement – TrustYes
2022-01-01Plan benefit arrangement – InsuranceYes
2022-01-01Plan benefit arrangement - TrustYes
2021: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2021 form 5500 responses
2021-01-01Type of plan entitySingle employer plan
2021-01-01This submission is the final filingNo
2021-01-01This return/report is a short plan year return/report (less than 12 months)No
2021-01-01Plan is a collectively bargained planNo
2021-01-01Plan funding arrangement – InsuranceYes
2021-01-01Plan funding arrangement – TrustYes
2021-01-01Plan benefit arrangement – InsuranceYes
2021-01-01Plan benefit arrangement - TrustYes
2020: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2020 form 5500 responses
2020-01-01Type of plan entitySingle employer plan
2020-01-01This submission is the final filingNo
2020-01-01This return/report is a short plan year return/report (less than 12 months)No
2020-01-01Plan is a collectively bargained planNo
2020-01-01Plan funding arrangement – InsuranceYes
2020-01-01Plan funding arrangement – TrustYes
2020-01-01Plan benefit arrangement – InsuranceYes
2020-01-01Plan benefit arrangement - TrustYes
2019: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2019 form 5500 responses
2019-01-01Type of plan entitySingle employer plan
2019-01-01Submission has been amendedNo
2019-01-01This submission is the final filingNo
2019-01-01This return/report is a short plan year return/report (less than 12 months)No
2019-01-01Plan is a collectively bargained planNo
2019-01-01Plan funding arrangement – TrustYes
2019-01-01Plan benefit arrangement - TrustYes
2018: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2018 form 5500 responses
2018-01-01Type of plan entitySingle employer plan
2018-01-01Submission has been amendedNo
2018-01-01This submission is the final filingNo
2018-01-01This return/report is a short plan year return/report (less than 12 months)No
2018-01-01Plan is a collectively bargained planNo
2018-01-01Plan funding arrangement – TrustYes
2018-01-01Plan benefit arrangement - TrustYes
2017: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2017 form 5500 responses
2017-01-01Type of plan entitySingle employer plan
2017-01-01Submission has been amendedNo
2017-01-01This submission is the final filingNo
2017-01-01This return/report is a short plan year return/report (less than 12 months)No
2017-01-01Plan is a collectively bargained planNo
2017-01-01Plan funding arrangement – TrustYes
2017-01-01Plan benefit arrangement - TrustYes
2016: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2016 form 5500 responses
2016-01-01Type of plan entitySingle employer plan
2016-01-01Submission has been amendedNo
2016-01-01This submission is the final filingNo
2016-01-01This return/report is a short plan year return/report (less than 12 months)No
2016-01-01Plan is a collectively bargained planNo
2016-01-01Plan funding arrangement – TrustYes
2016-01-01Plan benefit arrangement - TrustYes
2015: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2015 form 5500 responses
2015-01-01Type of plan entitySingle employer plan
2015-01-01Submission has been amendedNo
2015-01-01This submission is the final filingNo
2015-01-01This return/report is a short plan year return/report (less than 12 months)No
2015-01-01Plan is a collectively bargained planNo
2015-01-01Plan funding arrangement – TrustYes
2015-01-01Plan benefit arrangement - TrustYes
2014: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2014 form 5500 responses
2014-01-01Type of plan entitySingle employer plan
2014-01-01Submission has been amendedNo
2014-01-01This submission is the final filingNo
2014-01-01This return/report is a short plan year return/report (less than 12 months)No
2014-01-01Plan is a collectively bargained planNo
2014-01-01Plan funding arrangement – TrustYes
2014-01-01Plan benefit arrangement - TrustYes
2013: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2013 form 5500 responses
2013-01-01Type of plan entitySingle employer plan
2013-01-01Submission has been amendedNo
2013-01-01This submission is the final filingNo
2013-01-01This return/report is a short plan year return/report (less than 12 months)No
2013-01-01Plan is a collectively bargained planNo
2013-01-01Plan funding arrangement – TrustYes
2013-01-01Plan benefit arrangement - TrustYes
2012: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2012 form 5500 responses
2012-01-01Type of plan entitySingle employer plan
2012-01-01Submission has been amendedNo
2012-01-01This submission is the final filingNo
2012-01-01This return/report is a short plan year return/report (less than 12 months)No
2012-01-01Plan is a collectively bargained planNo
2012-01-01Plan funding arrangement – TrustYes
2012-01-01Plan benefit arrangement - TrustYes
2011: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2011 form 5500 responses
2011-01-01Type of plan entitySingle employer plan
2011-01-01Submission has been amendedNo
2011-01-01This submission is the final filingNo
2011-01-01This return/report is a short plan year return/report (less than 12 months)No
2011-01-01Plan is a collectively bargained planNo
2011-01-01Plan funding arrangement – TrustYes
2011-01-01Plan benefit arrangement - TrustYes
2010: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2010 form 5500 responses
2010-01-01Type of plan entitySingle employer plan
2010-01-01Submission has been amendedNo
2010-01-01This submission is the final filingNo
2010-01-01This return/report is a short plan year return/report (less than 12 months)No
2010-01-01Plan is a collectively bargained planNo
2010-01-01Plan funding arrangement – TrustYes
2010-01-01Plan benefit arrangement - TrustYes
2009: PHARMACEUTICS INTERNATIONAL, INC. 401(K) PROFIT SHARING PLAN AND TRUST 2009 form 5500 responses
2009-01-01Type of plan entitySingle employer plan
2009-01-01Submission has been amendedNo
2009-01-01This submission is the final filingNo
2009-01-01This return/report is a short plan year return/report (less than 12 months)No
2009-01-01Plan is a collectively bargained planNo
2009-01-01Plan funding arrangement – TrustYes
2009-01-01Plan benefit arrangement - TrustYes

Insurance Providers Used on plan

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )
Policy contract number613953
Policy instance 1
Insurance contract or identification number613953
Number of Individuals Covered432
Insurance policy start date2022-01-01
Insurance policy end date2022-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )
Policy contract number535593
Policy instance 2
Insurance contract or identification number535593
Number of Individuals Covered432
Insurance policy start date2022-01-01
Insurance policy end date2022-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )
Policy contract number613953
Policy instance 1
Insurance contract or identification number613953
Number of Individuals Covered396
Insurance policy start date2021-01-01
Insurance policy end date2021-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )
Policy contract number535593
Policy instance 2
Insurance contract or identification number535593
Number of Individuals Covered396
Insurance policy start date2021-01-01
Insurance policy end date2021-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )
Policy contract number613953
Policy instance 1
Insurance contract or identification number613953
Number of Individuals Covered415
Insurance policy start date2020-10-01
Insurance policy end date2020-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )
Policy contract number535593
Policy instance 2
Insurance contract or identification number535593
Number of Individuals Covered415
Insurance policy start date2020-10-01
Insurance policy end date2020-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S3